Related Experiment Video
Updated: Jul 23, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Using clinical risk models to predict outcomes: what are we predicting and why?
1School of Health and Related Research, The University of Sheffield, Sheffield, S10 2TN, UK s.goodacre@sheffield.ac.uk.
Clinical risk prediction models may misidentify patients unlikely to benefit from treatment. This paper explains how treatment effects impact model development and offers guidance for using prediction scores to aid, not dictate, clinical decisions.
Area of Science:
- Emergency Medicine
- Clinical Epidemiology
- Biostatistics
Background:
- Clinical risk prediction models are crucial for emergency medicine decision-making.
- Current models may inaccurately direct interventions towards high-risk patients.
- The influence of treatment effects on model development is often overlooked.
Purpose of the Study:
- To examine the impact of treatment effects on prognostic clinical risk prediction models.
- To identify how treatment effects can lead to misclassification of patient benefit.
- To provide practical advice for the appropriate use of clinical prediction scores.
Main Methods:
- Conceptual analysis of prognostic model development.
- Examination of potential biases introduced by treatment effects.
- Review of literature on clinical prediction score application.
Main Results:
- Treatment effects can cause risk prediction models to identify patients unlikely to benefit from intervention.
- Models may fail to identify patients most likely to benefit, hindering effective resource allocation.
- Misinterpretation of model outputs can lead to suboptimal clinical decision-making.
Conclusions:
- Clinicians should be aware of the potential for treatment effects to bias risk prediction models.
- Clinical prediction scores should augment, not replace, clinical judgment.
- Careful consideration of model development and application is necessary to ensure patient benefit.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...

